Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH alternative cancer therapy evaluation projects would originate in operations center.

This article was originally published in The Tan Sheet

Executive Summary

ALTERNATIVE CANCER THERAPY EVALUATION PROJECTS at NIH's Office of Alternative Medicine would originate at the OAM operations center under a proposed program from the National Institutes of Health. The Practice Outcomes Monitoring and Evaluation System (POMES) plan was presented by OAM and the National Cancer Institute at a meeting in Bethesda, Md. Aug. 4-6. Alternative cancer therapy studies to date mostly have focused on vitamin A and beta carotene.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087431

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel